Opinion|Videos|July 29, 2024
Out of Pocket Costs Associated with Biosimilar Use
The panel discusses out of pocket costs and the impact of the 340b program for various patient types.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Plastic in Personal Care Products Tied to Skin Disease and Environmental Pollution, Review Finds
2
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata
3
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
4
Endometriosis Reduces Ovarian Reserve via Inflammation and Surgery
5